These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 31092456)
1. Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer. Murakami Y; Saito H; Shimizu S; Kono Y; Shishido Y; Miyatani K; Matsunaga T; Fukumoto Y; Fujiwara Y Anticancer Res; 2019 May; 39(5):2583-2589. PubMed ID: 31092456 [TBL] [Abstract][Full Text] [Related]
2. Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer. Yu L; Lv CY; Yuan AH; Chen W; Wu AW World J Gastroenterol; 2015 May; 21(20):6280-6. PubMed ID: 26034363 [TBL] [Abstract][Full Text] [Related]
3. Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer. Ock CY; Nam AR; Lee J; Bang JH; Lee KH; Han SW; Kim TY; Im SA; Kim TY; Bang YJ; Oh DY Gastric Cancer; 2017 Mar; 20(2):254-262. PubMed ID: 27147244 [TBL] [Abstract][Full Text] [Related]
4. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer. Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485 [TBL] [Abstract][Full Text] [Related]
5. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer. Huang Z; Liu Y; Yang C; Li X; Pan C; Rao J; Li N; Liao W; Lin L BMC Cancer; 2018 May; 18(1):515. PubMed ID: 29720123 [TBL] [Abstract][Full Text] [Related]
6. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. Miyamoto R; Inagawa S; Sano N; Tadano S; Adachi S; Yamamoto M Eur J Surg Oncol; 2018 May; 44(5):607-612. PubMed ID: 29478743 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer. Zhang Y; Lu JJ; Du YP; Feng CX; Wang LQ; Chen MB Medicine (Baltimore); 2018 Mar; 97(12):e0144. PubMed ID: 29561419 [TBL] [Abstract][Full Text] [Related]
8. The neutrophil/lymphocyte ratio as a predictor of peritoneal metastasis during staging laparoscopy for advanced gastric cancer: a retrospective cohort analysis. Nakamura N; Kinami S; Fujii Y; Miura S; Fujita J; Kaida D; Tomita Y; Miyata T; Fujita H; Ueda N; Iida Y; Kosaka T World J Surg Oncol; 2019 Jun; 17(1):108. PubMed ID: 31238937 [TBL] [Abstract][Full Text] [Related]
9. A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms. Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM Oncotarget; 2016 Jul; 7(27):42045-42058. PubMed ID: 27275541 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence. Yamamoto M; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y World J Surg; 2016 Aug; 40(8):1904-9. PubMed ID: 26969673 [TBL] [Abstract][Full Text] [Related]
11. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study. Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772 [TBL] [Abstract][Full Text] [Related]
12. Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China. Zhu GS; Tian SB; Wang H; Ma MG; Liu Y; Du HS; Long YP Curr Med Sci; 2018 Feb; 38(1):78-84. PubMed ID: 30074155 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial. Grenader T; Waddell T; Peckitt C; Oates J; Starling N; Cunningham D; Bridgewater J Ann Oncol; 2016 Apr; 27(4):687-92. PubMed ID: 26787231 [TBL] [Abstract][Full Text] [Related]
15. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer. Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer. Namikawa T; Munekage E; Munekage M; Maeda H; Yatabe T; Kitagawa H; Kobayashi M; Hanazaki K Oncology; 2016; 90(6):321-6. PubMed ID: 27225990 [TBL] [Abstract][Full Text] [Related]
17. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313 [TBL] [Abstract][Full Text] [Related]
18. Clinical Relevance of Postoperative Neutrophil-Lymphocyte Ratio (NLR) to Recurrence After Adjuvant Chemotherapy of S-1 for Gastric Cancer. Tanaka H; Tamura T; Toyokawa T; Muguruma K; Miki Y; Kubo N; Sakurai K; Hirakawa K; Ohira M Anticancer Res; 2018 Jun; 38(6):3745-3751. PubMed ID: 29848737 [TBL] [Abstract][Full Text] [Related]
19. An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer. Mori M; Shuto K; Kosugi C; Narushima K; Hayashi H; Matsubara H; Koda K BMC Cancer; 2018 Dec; 18(1):1261. PubMed ID: 30558575 [TBL] [Abstract][Full Text] [Related]
20. Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination Chemotherapy. Hwang GY; Baek DW; Cho HJ; Lee SJ; Chae YS; Kang BW; Lee IH; Kim JG; Seo AN; Bae HI; Park KB; Park JY; Kwon OK; Lee SS; Chung HY Anticancer Res; 2018 May; 38(5):3151-3156. PubMed ID: 29715156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]